Zacks Investment Research on MSN
Here's why Quest Diagnostics (DGX) is a strong growth stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated ...
Being unpredictable and willing to change will be as important for Cardinals young pitchers as not being overwhelmed by the ...
Federal panel is expected to vote today on a new recommendation on hepatitis B vaccines for newborns. Man accused of planting ...
This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated ...
Although many companies using kiosks have some level of accessibility built in -- compliant height, reachable screens or ...
SAI360 announced today that it has acquired Plural Policy, an AI-driven regulatory intelligence company, purpose-built to analyze legislative and regulatory text at scale. The acquisition expands ...
Adversa AI, the pioneer in Agentic AI Security and Continuous AI Red Teaming, has been named the winner of the Cloud Security Alliance's Startup Pitchapalooza 2025, emerging at the top of a highly ...
Zacks Investment Research on MSN
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?
In the fast-growing diagnostics testing market, Hologic HOLX and Quest Diagnostics DGX stand out as two prominent players, each with its own niche. Hologic focuses on women’s health, providing a wide ...
Onward Medical N.V. ( OTC:ONWRF) Q3 2025 Earnings Call November 24, 2025 8:00 AM EST ...
Hims & Hers shows platform expansion, verticalization, new Labs offerings, slower FCF growth and strong long-term revenue targets. Learn why HIMS stock is a buy.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈